Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
2.050
-0.010 (-0.49%)
At close: Dec 5, 2025, 4:00 PM EST
2.040
-0.010 (-0.49%)
After-hours: Dec 5, 2025, 7:53 PM EST
Outlook Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Market Capitalization | 91 | 126 | 58 | 276 | 380 | 92 | |
| Market Cap Growth | -26.40% | 119.64% | -79.15% | -27.49% | 315.51% | 117.68% | |
| Enterprise Value | 117 | 127 | 59 | 260 | 372 | 73 | |
| Last Close Price | 2.05 | 5.34 | 4.42 | 24.40 | 43.40 | 14.40 | |
| PS Ratio | 39.40 | - | - | - | - | - | |
| PB Ratio | - | -1.73 | -3.98 | 31.58 | 82.58 | 32.40 | |
| P/TBV Ratio | - | - | - | 31.58 | 82.58 | 32.40 | |
| EV/Sales Ratio | 77.63 | - | - | - | - | - | |
| Debt / Equity Ratio | -0.93 | -0.41 | -2.46 | 1.25 | 2.58 | 1.71 | |
| Asset Turnover | 0.04 | - | - | - | - | - | |
| Quick Ratio | 0.34 | 0.35 | 0.50 | 0.88 | 2.14 | 0.84 | |
| Current Ratio | 0.67 | 0.64 | 0.66 | 1.40 | 3.19 | 1.13 | |
| Return on Equity (ROE) | - | - | - | -989.99% | -1430.33% | - | |
| Return on Assets (ROA) | -130.65% | -146.63% | -109.17% | -153.56% | -151.98% | -123.12% | |
| Return on Capital (ROIC) | - | - | -162.72% | -217.76% | -267.59% | -383.73% | |
| Return on Capital Employed (ROCE) | 798.30% | 522.20% | 368.10% | -716.90% | -322.10% | -944.70% | |
| Earnings Yield | -47.71% | -59.66% | -102.55% | -23.94% | -13.97% | -38.48% | |
| FCF Yield | -61.97% | -54.46% | -74.72% | -20.54% | -14.26% | -34.72% | |
| Buyback Yield / Dilution | -82.32% | -48.29% | -17.96% | -38.91% | -110.43% | -298.84% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.